论文部分内容阅读
AIM:To evaluate the prognostic factors of long-term survival of more than 3 years in patients with advanced non-small cell lung cancer(NSCLC).METHODS:We retrospectively analyzed the records of 474 patients with advancedⅢB/ⅣNSCLC who received chemotherapy